BioCentury
ARTICLE | Product Development

Dealmaking and bispecifics cut trail to IPO for Y-Biologics

Korea Spotlight: Y-Biologics’ in-house antibody technology key to series of global partnerships 

August 19, 2021 9:58 PM GMT
Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article